183 results on '"Ladeb, S."'
Search Results
2. Peripheral blood stem cell mobilization in multiple myeloma comparison of two consecutive regimens in a limited resources country
3. First report of pediatric hematopoietic stem cell transplantation activities in the eastern mediterranean region from 1984 to 2011: on behalf of the pediatric cancer working committee of the eastern mediterranean blood and marrow transplantation group
4. PB2338: QUALITY OF LIFE AFTER ALLOGENIC HEMATOPOIETIC STEM CELL TRANSPLANTATION: IMPACT OF CHRONIC GVHD
5. P1325: ACCURACY OF CRYOTUBE METHOD TO ASSESS PRETHAWING RICHNESS OF CRYOPRESERVED CD34+ HEMATOPOIETIC STEM CELLS FOR AUTOLOGOUS TRANSPLANTATION
6. Association of Stromal Cell–Derived Factor-1-3′A Polymorphism to Higher Mobilization of Hematopoietic Stem Cells CD34+ in Tunisian Population
7. Reduced intensity conditioning is effective for hematopoietic SCT in dyskeratosis congenita-related BM failure
8. Allogeneic matched-sibling hematopoietic cell transplantation for AML: comparable outcomes between Eastern Mediterranean (EMBMT) and European (EBMT) centers
9. OUTCOME OF AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT) IN MYELOMA PATIENT WITH PRIMARY INDUCTION FAILURE OR PROGRESSIVE DISEASE: PH-AB040
10. ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION (ALLO-HSCT) FOR CHRONIC MYELOID LEUKEMIA (CML): THE TUNISIAN EXPERIENCE: PH-P095
11. Retraction to: Allogeneic hematopoietic stem cell transplantation for acquired aplastic anemia using cyclophosphamide and antithymocyte globulin: a single center experience
12. Detection of catheter-related bloodstream infections by the Gram stain–acridine orange leukocyte cytospin test in hematopoietic stem cell transplant recipients
13. Prevalence of inherited prothrombotic abnormalities and central venous catheter-related thrombosis in haematopoietic stem cell transplants recipients
14. First-line thalidomide–dexamethasone therapy in preparation for autologous stem cell transplantation in young patients (<61 years) with symptomatic multiple myeloma
15. Difference in time to positivity is useful for the diagnosis of catheter-related bloodstream infection in hematopoietic stem cell transplant recipients
16. Salvage therapy with bortezomib in myeloma patients with relapse or progression after stem cell transplantation: P909
17. Bone marrow transplantation in Gaucher disease. An alternative to enzyme replacement therapy in a country with limited resources. Experience of the Centre National De Greffe De Moelle Osseuse, Tunisia: P629
18. Allogeneic hematopoietic stem cell transplantation in Tunisia
19. Severe neurotoxicity associated with dimethyl sulphoxide following PBSCT
20. First-line thalidomide-dexamethasone therapy in preparation for auto-SCT in young patients (<61 years) with symptomatic multiple myeloma
21. Perforation of the superior vena cava after subclavian catheterization: a rare complication after autologous PBSCT
22. Allogeneic hematopoietic stem cell transplantation in Tunisia
23. Analysis of cytomegalovirus (CMV) viremia using the pp65 antigenemia assay, the amplicor CMV test, and a semi-quantitative polymerase chain reaction test after allogeneic marrow transplantation
24. Prospective Randomised Comparison of the COBE Spectra Version 6 and Haemonetics MCS+ Cell Separators for Hematopoietic Progenitor Cells Leucapheresis in Patients With Multiple Myeloma
25. Bone marrow transplantation from matched related donors for patients with Fanconi anemia using low-dose busulfan and cyclophosphamide as conditioning
26. Plasmodium falciparum causing pancytopenia after allogeneic blood stem cell transplantation
27. The role of unfractionated heparin prophylaxis to prevent catheter-related thrombosis in patients with haemato-oncological diseases: a prospective randomised study
28. Les infections liées aux cathéters veineux centraux non tunnélisés chez des patients immunodéprimés : étude prospective à propos de 210 cas
29. PS1053 IMPACT OF CYTOMEGALOVIRUS REACTIVATION ON RELAPSE RATE AFTER ALLOGENEIC STEM CELL TRANSPLANTATION IN PATIENTS WITH ACUTE MYELOBLASTIC LEUKEMIA
30. PB1813 FRONTLINE AUTOLOGOUS STEM CELL TRANSPLANTATION IN PERIPHERAL T-CELL LYMPHOMA: A SINGLE CENTER EXPERIENCE
31. PB2173 OUTCOMES AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION IN MULTIPLE MYELOMA: IMPACT OF RENAL FAILURE
32. Retraction Note: Allogeneic hematopoietic stem cell transplantation for acquired aplastic anemia using cyclophosphamide and antithymocyte globulin: a single center experience
33. Retraction Note: First-line thalidomide–dexamethasone therapy in preparation for auto-SCT in young patients (<61 years) with symptomatic multiple myeloma
34. EXTRA MEDULLARY RELAPSE AFTER ALLOGENEIC BONE MARROW TRANSPLANTATION FOR MULTIPLE MYELOMA (MM)
35. Peripheral blood stem cell mobilization in multiple myeloma comparison of two consecutive regimens in a limited resources country
36. Complexe Candida parapsilosis : résultats préliminaires de l’identification moléculaire de 26 souches
37. Allogeneic hematopoietic stem cell transplantation for acquired aplastic anemia using cyclophosphamide and antithymocyte globulin: a single center experience
38. Perforation of the superior vena cava after subclavian catheterization: a rare complication after autologous PBSCT
39. Hodgkin Lymphoma (HL) in Tunisia Results of a 5 Year Prospective Multicenter Trial in 251 Pts
40. Bone marrow transplantation from matched related donors for patients with Fanconi anemia using low‐dose busulfan and cyclophosphamide as conditioning
41. Rejection of the second allogeneic graft in a child with Fanconi anemia reversed by antilymphocyte globulin and donor lymphocyte infusion
42. Facteurs de croissance et infection
43. Secondary alveolar proteinosis in cancer patients.
44. Fanconi anemia: Contribution of molecular analyses to the identification of bone marrow graft donors and the study of chimerism in grafted patients
45. Does multiple myeloma response induction therapy depending on plasma cell il6 receptor gene expression,L'expression de l'IL6-R par les plasmocytes influe-t-elle la réponse au traitement d'induction au cours du myélome multiple?
46. Cyclophosphamide and horse anti-thymocyte globulin versus fludarabine, reduced cyclophosphamide and rabbit anti-thymocyte globulin conditioning regimen for allogeneic hematopoietic stem cell transplantation from matched sibling donors in patients with acquired aplastic anemia.
47. Total body irradiation-based conditioning versus chemotherapy before allogeneic stem cell transplantation for adults with acute lymphoblastic leukemia.
48. Immunogenicity and Tolerance of BNT162b2 mRNA Vaccine in Allogeneic Hematopoietic Stem Cell Transplant Patients.
49. Venetoclax-azacitidine as salvage therapy for relapsed mixed phenotype acute leukemia after a second allogeneic hematopoietic stem cell transplantation: a case report.
50. Coagulase negative Staphylococcus bacteremia in hematopoietic stem cell transplant recipients: Clinical features and molecular characterization.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.